These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37528598)

  • 1. Associations Among Medical Therapy, SelfAdministered Exercise, and Characteristics of Ménière's Disease.
    Pyykkö I; Pyykkö N; Manchaiah V
    J Int Adv Otol; 2023 Jul; 19(4):323-332. PubMed ID: 37528598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the Self-training in Ménière's Disease Fit the Disease Characteristics and Help Alleviate the Balance Problems?
    Pyykkö I; Pyykkö N; Zou J; Manchaiah V
    J Int Adv Otol; 2022 Jan; 18(1):25-31. PubMed ID: 35193842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Intratympanic Gentamicin in Menière's Disease With and Without Migraine.
    Liu YF; Renk E; Rauch SD; Xu HX
    Otol Neurotol; 2017 Aug; 38(7):1005-1009. PubMed ID: 28538472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial).
    Adrion C; Fischer CS; Wagner J; Gürkov R; Mansmann U; Strupp M;
    BMJ; 2016 Jan; 352():h6816. PubMed ID: 26797774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic pharmacological interventions for Ménière's disease.
    Webster KE; Galbraith K; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015171. PubMed ID: 36827524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratympanic gentamicin for Ménière's disease.
    Webster KE; Galbraith K; Lee A; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015246. PubMed ID: 36847592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient Perceptions of Effectiveness in Treatments for Menière's Disease: a National Survey in Italy.
    Ward B; Wettstein V; Golding J; Corallo G; Nuti D; Trabalzini F; Mandala M
    J Int Adv Otol; 2019 Apr; 15(1):112-117. PubMed ID: 31058600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional, virtual reality vestibular rehabilitation for chronic imbalance problem caused by Ménière's disease: a pilot study.
    Hsu SY; Fang TY; Yeh SC; Su MC; Wang PC; Wang VY
    Disabil Rehabil; 2017 Aug; 39(16):1601-1606. PubMed ID: 27418422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive pressure therapy for Ménière's disease or syndrome.
    van Sonsbeek S; Pullens B; van Benthem PP
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD008419. PubMed ID: 25756795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratympanic corticosteroids for Ménière's disease.
    Webster KE; Lee A; Galbraith K; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Westerberg B; Burton MJ
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015245. PubMed ID: 36847608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Two cases of Meniere's disease with drop attacks].
    Goto F; Kunihiro T; Araki Y; Saito A; Ogawa K
    Nihon Jibiinkoka Gakkai Kaiho; 2005 Mar; 108(3):222-5. PubMed ID: 15828288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study of the efficacy and safety of a new modified-release betahistine formulation in the treatment of vestibular vertigo and Meniere's disease].
    Parfenov VA; Zamergrad MV; Kazei DV; Nauta J
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(12):42-48. PubMed ID: 33459540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vestibular syncope: A disorder associated with drop attack in Ménière's disease.
    Pyykkö I; Manchaiah V; Zou J; Levo H; Kentala E
    Auris Nasus Larynx; 2018 Apr; 45(2):234-241. PubMed ID: 28478076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vestibular drop attacks in Ménière's disease and its association with migraine.
    Pyykkö I; Pyykkö N; Manchaiah V
    Eur Arch Otorhinolaryngol; 2020 Jul; 277(7):1907-1916. PubMed ID: 32185501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report from a Consensus Conference on the treatment of Ménière's disease with betahistine: rationale, methodology and results.
    Casani AP; Guidetti G; Schoenhuber R;
    Acta Otorhinolaryngol Ital; 2018 Oct; 38(5):460-467. PubMed ID: 30498275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of streptomycin sulfate in the treatment of Meniere's disease.
    Silverstein H; Hyman SM; Feldbaum J; Silverstein D
    Otolaryngol Head Neck Surg; 1984 Apr; 92(2):229-32. PubMed ID: 6425780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The benefits of betahistine or vestibular rehabilitation (Tetrax biofeedback) on the quality of life and fall risk in patients with Ménière's disease.
    Liu JL; Liu JG; Chen XB; Liu YH
    J Laryngol Otol; 2020 Dec; 134(12):1073-1076. PubMed ID: 33280619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vestibular evoked myogenic potential (VEMP) in patients with Ménière's disease with drop attacks.
    Timmer FC; Zhou G; Guinan JJ; Kujawa SG; Herrmann BS; Rauch SD
    Laryngoscope; 2006 May; 116(5):776-9. PubMed ID: 16652086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Trimetazidine versus betahistine in vestibular vertigo. A double blind study].
    Kluyskens P; Lambert P; D'Hooge D
    Ann Otolaryngol Chir Cervicofac; 1990; 107 Suppl 1():11-9. PubMed ID: 2240994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical interventions for Ménière's disease.
    Lee A; Webster KE; George B; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015249. PubMed ID: 36825750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.